• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about VIR

Recent news which mentions VIR

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stocks That Hit 52-Week Lows On Monday
March 07, 2022
Tickers VEEV VFC VFF VIOT
Tags VVI VLDR Benzinga
From Benzinga
Here's Why This Under-the-Radar Biotech Is at the Top of My Buy List
March 04, 2022
Tickers BNTX GSK LLY PFE
Tags GSK VIR PFE
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
March 03, 2022
Tickers ALGT AORT AVTX BALY
Tags CCSI GOCO WEAV
From Benzinga
Where to Invest $10,000 in a Bear Market
March 02, 2022
Tickers SE SHOP VIR WTI
Tags Market News SHOP WTI
From Motley Fool
Stocks That Hit 52-Week Lows On Monday
February 28, 2022
Tickers AAOI ALPA AMBC AMYT
Tags VEON LXEH HMPT
From Benzinga
Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach
February 28, 2022
Tickers GSK LLY NNVC REGN
Tags Partner Content NanoViricides Penny Stocks
From Benzinga
AstraZeneca, GSK's COVID-19 Therapies Lose Efficacy Against Omicron's Subvariants
February 25, 2022
Tickers AZN AZNCF GSK VIR
Tags Health Care AZNCF News
From Benzinga
Recap: Vir Biotechnology Q4 Earnings
February 24, 2022
Tickers VIR
Tags Benzinga VIR Earnings
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Tickers ABCL ADGI AGIO ARYD
Tags TMDX Penny Stocks FOLD
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 23, 2022
Tickers KBH KD KERN KIO
Tags UAVS REAL SBUX
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Tickers ABCL AGIO ARNA ATXI
Tags PCRX YMAB BHC
From Benzinga
3 Biotech Stocks That Are too Cheap to Ignore
February 10, 2022
Tickers GSK ICPT LLY REGN
Tags ICPT GSK VIR
From Motley Fool
Preprint Suggests, Vir-GSK's COVID-19 Antibody Can Evade Omicron Sub-Variant
February 10, 2022
Tickers GSK LLY VIR
Tags Biotech Market News COVID/19 Coronavirus
From Benzinga
Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus
February 08, 2022
Tickers GSK IMNM VIR
Tags News Health Care Market News
From Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Tickers ALKS AMGN AXSM BIIB
Tags Guidance General AXSM
From Benzinga
‘You will not believe what I’ve just found.’ Inside the ivermectin saga: a hacked password, mysterious websites and faulty data
February 07, 2022
Tickers GILD GSK LLY MRK
Tags CH:ROG GILD GSK
From MarketWatch
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
February 04, 2022
Tickers GILD GSK LLY MRK
Tags PFE LLY GILD
From MarketWatch
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
Tickers BNTX GILD GSK MRK
Tags GILD GSK VIR
From MarketWatch
2 Best COVID-19 Growth Stocks to Own in 2022
January 17, 2022
Tickers GSK NVAX VIR
Tags Market News Recent Press Releases VIR
From Motley Fool
WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge
January 14, 2022
Tickers GSK LLY REGN VIR
Tags REGN Market News General
From Benzinga
2 Top Healthcare Stocks to Buy Right Now
January 14, 2022
Tickers GILD GSK MRK VIR
Tags Recent Press Releases MRK GILD
From Motley Fool
GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19
January 13, 2022
Tickers GSK VIR
Tags Benzinga COVID/19 Coronavirus Briefs
From Benzinga
Vir Biotechnology Expands Partnership With Bill & Melinda Gates Foundation, Launches New Antibody Research Initiative Aimed At A Functional Cure For HIV And Prevention Of Malaria; Foundation Has Commi
January 13, 2022
Tickers VIR
Tags General Market News Biotech
From Benzinga
Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies
January 13, 2022
Tickers ADGI AZN AZNCF GSK
Tags News AZNCF Health Care
From Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
January 13, 2022
Tickers ADGI BTCS DUO ECOR
Tags ADGI Pre/Market Movers ECOR
From Benzinga
50 Biggest Movers From Yesterday
January 13, 2022
Tickers AACG ACRS AVGR BBIG
Tags SURG QTT Pre/Market Outlook
From Benzinga
US To Purchase 600K Additional Doses of GSK-Vir's COVID-19 Antibody Therapy
January 11, 2022
Tickers GSK VIR
Tags Market News Biotech Benzinga
From Benzinga
London stocks ride a global bounce, with retailers and energy names higher
January 11, 2022
Tickers AZN BP GSK RDS-A
Tags UK:TSCO UK:BP RDS/A
From MarketWatch
My 3 Top Biotech Stock Picks for 2022
January 09, 2022
Tickers AMGN BEAM GSK VIR
Tags BEAM Recent Press Releases AMGN
From Motley Fool
3 COVID Stocks That Will Make Billions in 2022
January 07, 2022
Tickers NVAX PFE VIR
Tags VIR NVAX Recent Press Releases
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap